Tumour suppressors hamartin and tuberin: intracellular signalling.
about
Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactorAmino acids as regulators of gene expressionBiochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activityAbnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2Cardiac tumours in infancyReal-time monitoring of tumorigenesis, dissemination, & drug response in a preclinical model of lymphangioleiomyomatosis/tuberous sclerosis complexHuman papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberinGenetic insights into familial tumors of the nervous systemTSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPaseTOR signaling.Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberinInterferons modulate mitogen-induced protein synthesis in airway smooth muscle.Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expressionMicroRNA and protein profiling of brain metastasis competent cell-derived exosomes.ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.Cardiac tumours in childrenMetabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex.Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.Congenital/inherited kidney diseases: how to identify them early and how to manage them.Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphansTwo novel TSC2 mutations in Chinese patients with tuberous sclerosis complex and a literature review of 20 patients reported in China.S6 kinase 2 potentiates interleukin-3-driven cell proliferationTargeting the phosphatidylinositol 3-kinase pathway in airway smooth muscle: rationale and promise.A Chinese tuberous sclerosis complex family and a novel tuberous sclerosis complex-2 mutationPostnatal ontogeny of skeletal muscle protein synthesis in pigsThe TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway.Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.Activation of signaling pathways and regulatory mechanisms of mRNA translation following myocardial ischemia-reperfusion.Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.Insulin and Amino Acids Are Critical Regulators of Neonatal Muscle Growth.Activation by insulin and amino acids of signaling components leading to translation initiation in skeletal muscle of neonatal pigs is developmentally regulated.PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's diseaseTSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase.Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress.Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma.Clinical management of tuberous sclerosis complex over the lifetime of a patient.Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.Developmental regulation of the activation of signaling components leading to translation initiation in skeletal muscle of neonatal pigs.
P2860
Q24305619-C9B16A32-DDAC-458B-9CDA-06CB81844CEFQ24562847-C13BAF97-34BE-48A5-B90B-83A421DB4955Q24563018-1AEE4821-6173-4516-99D7-06FD95609A04Q24651443-BACD5DD0-398A-4A92-BDBB-44984A7D60BEQ26859853-465734FB-BF34-43AD-BECE-7D2CC7D228ECQ27301399-2E454EF5-109C-4195-9B55-BF51C2E2CD96Q28264728-432429BF-9E4E-4D86-9823-426DD9673116Q28272951-6E70F74D-F7FC-4309-9339-1C7746593781Q28583834-A30F718D-48B9-4647-A342-66F414CF90EFQ30312086-D5E10E95-713A-48DF-A95E-450164D8B1E1Q30459608-6952BF97-27A1-462A-A922-71E6B847B73BQ33994643-56F2F59C-8842-4DD2-A475-BC94C4B26820Q34427178-9AABA7C4-EC41-494E-94CD-F284A8968271Q34656781-6DDD9DF1-A988-4F68-B5ED-77C3CF36F4A9Q34997093-4ACFD5BD-B953-47E9-97F1-A01D6974C958Q35385732-6E6DD6B4-FA15-4F9F-997D-84A2130E626AQ35578048-3A343FB3-0C59-4AA5-9357-35E169096A87Q35748464-A487BA37-A472-4981-A5E9-F4D9D5C50113Q36067011-E4A6E332-ECCE-4BDF-B30E-03AC586B1A6BQ36270433-A8ECFA8E-BCE6-4BC0-8A26-A228670181CFQ36330644-218830C7-08E5-43E2-A806-FC72A638821BQ36620770-4641B00D-B162-40D4-9C83-A258258B93BAQ36713845-3994D671-DB5A-43E0-BB79-C23F95605DC5Q36777789-5215A633-D091-499F-91E4-ED58CA7C7470Q36816163-BF3F059F-619C-4A7A-A7EC-495E144C92F4Q36929171-BD25066D-924C-4170-9FAA-04EEAB230742Q37003173-F440AF81-8659-4707-B454-68A39E358840Q37038088-410C0E42-7E77-4325-98F5-255B6DB4A9B1Q37073356-9CE035FF-4A4C-46DE-B9E4-0D8DF315D738Q37101089-90B8AA69-596E-48B9-8B76-1EA99CA78969Q37153372-72586AB1-89AD-4796-AE78-F659A046CBD1Q37272162-AF4440B5-E975-4440-A7B8-2FA3E9A13EB4Q37310632-1B935F75-60E8-485A-9C91-4C48D2934396Q40319463-C1B21B4F-0D9E-48D3-96DD-821622BE806EQ45005978-4D64EE4E-56CC-440B-BC7F-472BC65ADD66Q45185112-6C0A1997-2012-433A-BEF3-D7317B373E24Q46976979-B9BEEFF2-8D01-406F-921D-1DABE58D2B5DQ47826008-9ECD4AC9-4C39-44D3-AC2C-453C67A7F2F6Q51779283-0E0F6508-BABA-489B-91A6-5F8EC356FDFDQ52015841-78C85074-EA84-48D0-B0DD-BD00A158796B
P2860
Tumour suppressors hamartin and tuberin: intracellular signalling.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumour suppressors hamartin and tuberin: intracellular signalling.
@ast
Tumour suppressors hamartin and tuberin: intracellular signalling.
@en
type
label
Tumour suppressors hamartin and tuberin: intracellular signalling.
@ast
Tumour suppressors hamartin and tuberin: intracellular signalling.
@en
prefLabel
Tumour suppressors hamartin and tuberin: intracellular signalling.
@ast
Tumour suppressors hamartin and tuberin: intracellular signalling.
@en
P1433
P1476
Tumour suppressors hamartin and tuberin: intracellular signalling.
@en
P2093
Vera P Krymskaya
P304
P356
10.1016/S0898-6568(03)00040-8
P577
2003-08-01T00:00:00Z